
Failure to Reach the Goal of Measles EliminationApparent Paradox of Measles Infections in Immunized Persons
Gregory A. Poland, MD;
Robert M. Jacobson, MD
Arch Intern Med. 1994;154(16):1815-1820.
Abstract
 |  |
Background Measles is the most transmissible disease known to man. During the 1980s, the number of measles cases in the United States rose dramatically. Surprisingly, 20% to 40% of these cases occurred in persons who had been appropriately immunized against measles. In response, the United States adopted a two--dose universal measles immunization program. We critically examine the effect of vaccine failure in measles occurring in immunized persons.
Methods We performed a computerized bibliographic literature search (National Library of Medicine) for all English-language articles dealing with measles outbreaks. We limited our search to reports of US and Canadian school-based outbreaks of measles, and we spoke with experts to get estimates of vaccine failure rates. In addition, we devised a hypothetical model of a school where measles immunization rates could be varied, vaccine failure rates could be calculated, and the percentage of measles cases occurring in immunized students could be determined.
Results We found 18 reports of measles outbreaks in very highly immunized school populations where 71% to 99.8% of students were immunized against measles. Despite these high rates of immunization, 30% to 100% (mean, 77%) of all measles cases in these outbreaks occurred in previously immunized students. In our hypothetical school model, after more than 95% of schoolchildren are immunized against measles, the majority of measles cases occur in appropriately immunized children.
Conclusions The apparent paradox is that as measles immunization rates rise to high levels in a population, measles becomes a disease of immunized persons. Because of the failure rate of the vaccine and the unique transmissibility of the measles virus, the currently available measles vaccine, used in a single-dose strategy, is unlikely to completely eliminate measles. The longterm success of a two-dose strategy to eliminate measles remains to be determined.
(Arch Intern Med. 1994;154:1815-1820)
Author Affiliations
From the Departments of Internal Medicine (Dr Poland) and Pediatrics and Adolescent Medicine (Dr Jacobson), Mayo Vaccine Research Group, Mayo Clinic and Foundation, Rochester, Minn.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Development of a Novel Efficient Fluorescence-Based Plaque Reduction Microneutralization Assay for Measles Virus Immunity
Haralambieva et al.
CVI 2008;15:1054-1059.
ABSTRACT
| FULL TEXT
Identification and Characterization of Novel, Naturally Processed Measles Virus Class II HLA-DRB1 Peptides
Ovsyannikova et al.
J. Virol. 2004;78:42-51.
ABSTRACT
| FULL TEXT
Frequency of Measles Virus-Specific CD4+ and CD8+ T Cells in Subjects Seronegative or Highly Seropositive for Measles Vaccine
Ovsyannikova et al.
CVI 2003;10:411-416.
ABSTRACT
| FULL TEXT
Effect of Differing Immunization Policies on Circulating Measles Antibody Levels in US and Canadian Children
Poland et al.
Mayo Clin Proc. 2002;77:446-452.
ABSTRACT
|